Unlock instant, AI-driven research and patent intelligence for your innovation.

A tenofovir prodrug or pharmaceutically acceptable salt and its application in medicine

A technology for medicinal salts and medicines, which can be applied to tenofovir prodrugs or medicinally acceptable salts and their application fields in medicine, and can solve problems such as technical barriers and the like

Active Publication Date: 2020-11-24
厦门一先药业有限公司 +1
View PDF11 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, due to technical barriers, patent restrictions, and price factors, it will take a long time for TAF to be introduced in China

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A tenofovir prodrug or pharmaceutically acceptable salt and its application in medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] step 1:

[0033] .

[0034] The mixture of tenofovir (70.5 g), triethylamine, DMAP, triphenyl phosphite and acetonitrile was refluxed at 80°C for 48 hours, then the heating was stopped, the acetonitrile was removed by rotary evaporation, and the fractions were extracted with water, ethyl acetate and acetonitrile respectively. liquid. Concentrated hydrochloric acid (30%) was added dropwise to the aqueous phase at low temperature (≤25°C) until the pH was 3, and the stirring was continued until solids were precipitated. Continue to add concentrated hydrochloric acid dropwise until the pH is less than 2. After filtering and drying, 73.1 g of white powdery solid IIA was obtained, with a yield of 81.57%. MS(m / z):364.1(M+H) + .

[0035] Step 2:

[0036] .

[0037] Thionyl chloride (336 mg) was added to IIA (513 mg) in acetonitrile mixture, stirred at 80°C for 5 h, a solid was precipitated, the acetonitrile was distilled off under reduced pressure, the solid was adde...

Embodiment 2

[0043] .

[0044] Thionyl chloride (336 mg) was added to IIA (513 mg) in acetonitrile mixture, stirred at 80°C for 5 h, a solid was precipitated, the acetonitrile was distilled off under reduced pressure, the solid was added with toluene and then spin-dried. The solid was then dissolved in dichloromethane, and a mixed solution of IIIA (337 mg) and dichloromethane was added dropwise at -30°C. After dropping, continue to add triethylamine dropwise until the pH is 6-7 after stirring for 5 minutes. After dropping, continue to react for 1 hour. Raise the temperature to -5°C, wash with sodium dihydrogen phosphate dihydrate solution, sodium bicarbonate solution, and saturated brine successively, dry with anhydrous sodium sulfate, spin dry, and obtain 482 mg of light yellow oil after column chromatography, yield 71.5% .

[0045] 1 H-NMR (400MHz, CDCl 3 )δ8.35(s, 1H), 7.94(m, 1H), 7.30~7.43(m, 1H), 7.21~7.35(m, 1H), 7.0~7.21(m, 2H), 6.80~6.99(m, 1H), 5.50~5.65(m, 2H), 4.58~4.92(...

Embodiment 3

[0048] Example 3: Compounds D and D1 were synthesized in a similar manner to compounds C and C1.

[0049] .

[0050] D: 1 H-NMR (400MHz, CDCl 3 ( m, 4H), 4.38~4.48(m, 1H), 4.01~4.20(m, 4H), 3.60~3.74(m, 2H), 1.28~1.50(m, 9H).

[0051] D1: MS(m / z):523.2(M+H) + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to tenofovir prodrug and application thereof in medicines. Specifically, the invention relates to a compound shown as general formula (I) or general formula (II), or isomers andpharmaceutical salts thereof, and application in preparation of drugs for treatment of viral infectious diseases, especially (HIV) infection, hepatitis B and hepatitis B virus induced diseases. Specifically, definitions of the substituent groups in the general formula (I) or general formula (II) are identical to those in the specification.

Description

technical field [0001] The invention relates to a tenofovir prodrug or pharmaceutically acceptable salt and its application in medicine. Background technique [0002] Hepatitis B virus (hepatitis B virus) refers to the DNA virus that causes human acute hepatitis and chronic hepatitis, referred to as HBV. According to the statistics of the World Health Organization, there are 2 billion people infected with hepatitis B virus in the world, and more than 350 million people suffer from chronic (long-term) liver infection diseases, among which the hepatitis B patients in China account for about 1 / 3. With a total cost of more than 100 billion, it has become the world's largest hepatitis B drug market. The probability of chronic hepatitis B patients developing liver cirrhosis or hepatocellular carcinoma is 15%-40%. Globally, 1 million people die from chronic hepatitis B every year, and hepatitis B is currently considered to be incurable, so antiviral is considered one of them. The...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F9/6561A61K31/685A61P31/18A61P31/20A61P1/16
CPCC07F9/65616
Inventor 顾世海丁延辉
Owner 厦门一先药业有限公司